Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:approvalYear |
1986
|
| gptkbp:approvedBy |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:ATCCode |
gptkb:J07BC01
|
| gptkbp:broadcastOn |
3-dose series
|
| gptkbp:contains |
hepatitis B surface antigen
|
| gptkbp:contraindication |
severe allergic reaction to previous dose
allergy to yeast |
| gptkbp:form |
suspension for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Recombivax HB
|
| gptkbp:indication |
adults
children infants |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue headache injection site soreness |
| gptkbp:storage |
2–8°C
|
| gptkbp:type |
recombinant vaccine
|
| gptkbp:usedFor |
hepatitis B prevention
|
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:MRK
|
| gptkbp:bfsLayer |
5
|